Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact

OBJECTIVE: To evaluate the clinical impact of nationwide implementation of genome‐wide non‐invasive prenatal testing (NIPT) in pregnancies at increased risk for fetal trisomies 21, 18 and 13 (TRIDENT study). METHOD: Women with elevated risk based on first trimester combined testing (FCT ≥ 1:200) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Oepkes, Dick, Page‐Christiaens, G. C. (Lieve), Bax, Caroline J., Bekker, Mireille N., Bilardo, Catia M., Boon, Elles M. J., Schuring‐Blom, G. Heleen, Coumans, Audrey B. C., Faas, Brigitte H., Galjaard, Robert‐Jan H., Go, Attie T., Henneman, Lidewij, Macville, Merryn V. E., Pajkrt, Eva, Suijkerbuijk, Ron F., Huijsdens‐van Amsterdam, Karin, Van Opstal, Diane, Verweij, E. J. (Joanne), Weiss, Marjan M., Sistermans, Erik A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214231/
https://www.ncbi.nlm.nih.gov/pubmed/27750376
http://dx.doi.org/10.1002/pd.4945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214231/
https://www.ncbi.nlm.nih.gov/pubmed/27750376
http://dx.doi.org/10.1002/pd.4945

Ejemplares similares